Hepato- and thyreotoxicity of tifemoxone.
The oral toxicity of Tifemoxone, phenoxymethyl-6 tetrahydroxazine-1, 3 thione-2, a new potential antidepressant was studied during 6 months in rats at 30, 85 and 230 mg/kg/d and in beagle dogs at 10, 55 and 300 mg/kg/d. Thyroid hyperplasia and hypoactivity were observed in the rats and dogs plasma triiodothyronine, determined in dogs, was modified. A dose dependent hepatotoxic effect was observed in the rats and dogs. In dogs at low dose, one animal died after B.S.P. test. Water consumption and urinary volume increased, weight loss and anemia appeared at high doses in both rats and dogs. Hair loss was observed in rats and convulsions in dogs. In conclusion, Tifemoxone like tetrahydroxazine thione and some derivatives caused thyreotoxicity, hairlessness and increased in water comsumption and diuresis and in addition it had strong hepatotoxic effect especially in the dog.
D000818:Animals; D000928:Antidepressive Agents / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004285:Dogs; D005260:Female; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced; D010078:Oxazines / Q000633:toxicity*; D051381:Rats; D013959:Thyroid Diseases / Q000139:chemically induced*; D013997:Time Factors
D000928:Antidepressive Agents; D010078:Oxazines